CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • CSL (ASX: CSL)
    Latest News

    Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
    Healthcare Shares

    What did CSL have to say at Macquarie's 2025 conference?

    Does this business have a healthy growth outlook?

    Read more »

    Person holding Australian dollar notes, symbolising dividends.
    How to invest

    Should I spend $5,000 on ASX 200 shares or ASX ETFs this month?

    Where is the best place to invest these funds? Let's look at the options.

    Read more »

    A man and woman dance back to back as they cook in kitchen.
    Share Market News

    ASX 200 'safe-haven' shares delivered divergent performances last week

    ASX 200 utilities shares lifted while healthcare shares tanked last week.

    Read more »

    A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
    How to invest

    How a beginner investor could build a $250,000 ASX share portfolio

    These easy steps could help you on your way to riches in the share market.

    Read more »

    Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
    Cheap Shares

    2 ASX 200 shares with favourable risk-reward profiles

    I think these two blue chips are worth a look right now.

    Read more »

    A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
    Share Market News

    3 key takeaways from the 2025 Macquarie Conference

    More than one hundred companies presented at the Macquarie Conference this year. Here’s what we learned.

    Read more »

    Three happy office workers cheer as they read about good financial news on a laptop.
    Blue Chip Shares

    3 of the best ASX 200 shares to buy now with $5,000

    Investors with money to invest might want to check out these shares that analysts rate as buys.

    Read more »

    Happy young woman saving money in a piggy bank.
    How to invest

    How to build a $100k ASX share portfolio with just $250 a month

    This is the easy way to build a sizeable investment portfolio without breaking the bank.

    Read more »

    Two men and a woman sitting in a subway train side by side, reading newspapers.
    How to invest

    My checklist when reviewing potential ASX200 investments

    Here's what helps me decide which shares to buy.

    Read more »

    Beautiful holiday photo showing two deck chairs close-up with people sitting in them enjoying the bright blue ocean and island view while sipping champagne and enjoying the good life thanks to Pilbara Minerals share price gains in recent times
    Blue Chip Shares

    3 ASX 200 blue chips to compound your way to riches

    Analysts think these blue chips would be top picks for buy and hold investors.

    Read more »

    man helping couple use a tablet
    How to invest

    Risk management: why rebalancing your portfolio is the ultimate tool

    Let's see how rebalancing a portfolio can help protect it.

    Read more »

    Man looking upwards contemplating which shares to buy
    Broker Notes

    CSL shares have climbed 10% since 11 April. Is it too late to buy?

    What are analysts saying about this biotech giant after its recent rally? Let's find out.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note